image of Fundamental and Clinical Pharmacology

Fundamental and Clinical Pharmacology

Editors:
Pascal Bousquet and Emmanuel Oger
Publisher:
Wiley
2020 Journal Impact Factor:
2.748 (Journal Citation Report, Web of Science Group)
ISSN:
0767-3981
Print/PDF
Request Information
Register for eToc Alerts
View Popular Articles
  • Description
  • Details
  • Also Recommended
Description

Published on behalf of the Société Française de Pharmacologie and of the Federation of the European Pharmacological Societies, EPHAR, Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology including:

Antimicrobial, Antiviral Agents

Autonomic Pharmacology

Cardiovascular Pharmacology

Endocrinopharmacology

Inflammation & Immunopharmacology

Liver & G-I Tract Pharmacology

Metabolism, Pharmacokinetics & Pharmacogenetics

Neuropharmacology

Oncology

Pediatric Pharmacology & Development

Pharmacoeconomics

Pharmacoepidemiology & Clinical Trials

Pharmacogenetics & Gene Therapy

Pulmonary Pharmacology

Renal Pharmacology

Thrombosis & Hemostasis

Clinical research, including clinical studies and clinical trials, may cover disciplines such as pharmacokinetics, pharmacodynamics, pharmacovigilance, pharmacoepidemiology, pharmacogenomics and pharmacoeconomics. Basic research articles from fields such as physiology and molecular biology which contribute to an understanding of drug therapy are also welcomed.

Includes Fundamental and Clinical Pharmacology: Supplement
Details
Platform:
OvidSP
Publisher:
Wiley
Product Type:
Journal
Author:
Pascal Bousquet and Emmanuel Oger
ISSN:
0767-3981
Specialty:
  • Pharmacology
  • Pharmacy
Language:
English
Update Frequency:
Bi-Monthly
Coverage:
February 2001 - Present
Pdf Coverage:
February 2001 - Present
2020 Journal Impact Factor:
2.748 (Journal Citation Report, Web of Science Group)

Request Information